Allelic variation in
HLA‐DRB1
is associated with development of a
ntidrug
antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro
Clinical and Translational Science（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要